Glucocerebrosidase is defective in PD fibroblasts carrying GBA1 mutations.
Ambroxol increases glucocerebrosidase activity and protein levels in all cells.
Ambroxol increases saposin C protein levels and cathepsin D activity in all cells.
Ambroxol increases LIMP-2 levels only in GBA1-mutant PD cells.